Sanders Moves to Subpoena CEOs Over High Drug Prices

In a bold move aimed at addressing the soaring costs of prescription drugs in the United States, Senator Bernie Sanders, chair of the Senate Committee on Health, Education, Labor, and Pensions, has announced plans to subpoena the CEOs of pharmaceutical giants Johnson & Johnson and Merck. The decision comes as part of an effort by Democratic lawmakers to hold pharmaceutical companies accountable for the exorbitant prices of medications.

Democratic lawmakers want answers about why prescription drug costs are so high in the U.S.

Sanders, a vocal advocate for healthcare reform and affordable prescription drugs, expressed frustration with. . .